成大生物(688739.SH)：本溪子公司通过药品GMP符合性检查

智通财经03-09

智通财经APP讯，成大生物(688739.SH)发布公告，公司全资子公司成大生物(本溪)有限公司(简称“本溪子公司”)近日收到辽宁省药品监督管理局签发的《药品GMP符合性现场检查结果通知书》(编号：辽26010013)。本溪子公司生产基地生产的冻干人用狂犬病疫苗(人二倍体细胞)已通过药品生产质量管理规范符合性检查。本溪子公司本次通过药品GMP符合性检查，标志着其生产基地已具备冻干人用狂犬病疫苗(人...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2618645642?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-09 16:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618645642","market":"us","top_or_hot":-1,"title":"成大生物(688739.SH)：本溪子公司通过药品GMP符合性检查","media":"智通财经","content":"<div>\n<p>智通财经APP讯，成大生物(688739.SH)发布公告，公司全资子公司成大生物(本溪)有限公司(简称“本溪子公司”)近日收到辽宁省药品监督管理局签发的《药品GMP符合性现场检查结果通知书》(编号：辽26010013)。本溪子公司生产基地生产的冻干人用狂犬病疫苗(人二倍体细胞)已通过药品生产质量管理规范符合性检查。本溪子公司本次通过药品GMP符合性检查，标志着其生产基地已具备冻干人用狂犬病疫苗(人...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411586.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>成大生物(688739.SH)：本溪子公司通过药品GMP符合性检查</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n成大生物(688739.SH)：本溪子公司通过药品GMP符合性检查\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-09 16:07 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1411586.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，成大生物(688739.SH)发布公告，公司全资子公司成大生物(本溪)有限公司(简称“本溪子公司”)近日收到辽宁省药品监督管理局签发的《药品GMP符合性现场检查结果通知书》(编号：辽26010013)。本溪子公司生产基地生产的冻干人用狂犬病疫苗(人二倍体细胞)已通过药品生产质量管理规范符合性检查。本溪子公司本次通过药品GMP符合性检查，标志着其生产基地已具备冻干人用狂犬病疫苗(人...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1411586.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688739","symbol_name":"成大生物","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1411586.html","article_id":"2618645642","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618645642","pubTimestamp":1773043644,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，成大生物 发布公告，公司全资子公司成大生物(本溪)有限公司近日收到辽宁省药品监督管理局签发的《药品GMP符合性现场检查结果通知书》。本溪子公司生产基地生产的冻干人用狂犬病疫苗已通过药品生产质量管理规范符合性检查。本溪子公司本次通过药品GMP符合性检查，标志着其生产基地已具备冻干人用狂犬病疫苗商业化生产条件，生产质量管理体系符合药品监管相关规范要求。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688739":"成大生物","BK0239":"医药制造"},"translate_title":"Chengda Biotech (688739.SH): Benxi subsidiary passes drug GMP compliance inspection","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688739":1.5},"content_text":"智通财经APP讯，成大生物(688739.SH)发布公告，公司全资子公司成大生物(本溪)有限公司(简称“本溪子公司”)近日收到辽宁省药品监督管理局签发的《药品GMP符合性现场检查结果通知书》(编号：辽26010013)。本溪子公司生产基地生产的冻干人用狂犬病疫苗(人二倍体细胞)已通过药品生产质量管理规范符合性检查。本溪子公司本次通过药品GMP符合性检查，标志着其生产基地已具备冻干人用狂犬病疫苗(人二倍体细胞)商业化生产条件，生产质量管理体系符合药品监管相关规范要求。本次检查通过有利于进一步完善公司疫苗生产体系与质量管控能力，保障产品稳定供应，持续提升公司在人用狂犬病疫苗领域的核心竞争力与优势市场地位，对公司未来经营发展具有重要积极意义。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618645642","isCrawlerRequest":true}